🔎 Trials Near Me

Pradžia › Gimdos kaklelio vėžys › Masčusetsas › Boston

Gimdos kaklelio vėžys klinikiniai tyrimai Boston, MA

18 tyrimai dėl Gimdos kaklelio vėžys ieško dalyvių vietose Boston ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Distance-Based Exercise to Preserve Function and Prevent Disability

Renkami dalyviai
  • Dana-Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07059884

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Renkami dalyviai1 fazė
  • Massachusetts General Hospital, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06465069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Renkami dalyviai2 fazė
  • Dana-Farber Cancer Institute - Oncology Department, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06760819

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Renkami dalyviai1/2 fazė
  • Tufts Medical Center, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT06047379

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Renkami dalyviai1 fazė
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT05983432

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Renkami dalyviai1/2 fazė
  • Massachusetts General Hospital, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT07109726

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Renkami dalyviai1 fazė
  • Dana Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06293898

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Renkami dalyviai1 fazė
  • Mass General Cancer Center, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-27 · NCT07227168

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Renkami dalyviai1 fazė
  • Normunity Investigational Site, Boston
  • Normunity Investigational Site, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT07182149

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Renkami dalyviai1/2 fazė
  • Massachusetts General Hospital Cancer Center, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-11 · NCT05592626

Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT

Renkami dalyviai
  • Massachusetts General Brigham, Boston
Amžius nuo 21 iki 70 · Moterims · Atnaujinta 2026-08-07 · NCT06872346

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Renkami dalyviai1/2 fazė
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-07 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Renkami dalyviai1 fazė
  • Massachusetts General Hospital, Boston
  • Brigham & Women's Hospital, Boston
  • Beth Israel Deaconess Medical Center,East Campus Research Pharmacy, Boston
  • ir dar 2
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-06 · NCT04389632

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Renkami dalyviai1/2 fazė
  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-23 · NCT06993844

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Renkami dalyviai1/2 fazė
  • Massachusetts General Hospital, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-06 · NCT06239194

Building Connections

Renkami dalyviai
  • Disparities Research Unit, Massachusetts General Hospital, Boston
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2025-11-18 · NCT07091032

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Renkami dalyviai2 fazė
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Moterims · Atnaujinta 2025-11-05 · NCT06677190

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Renkami dalyviai1/2 fazė
  • Dana Farber Cancer Institute, Boston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-09-24 · NCT05941507

Gimdos kaklelio vėžys tyrimai kituose miestuose

Kiti tyrimai Boston

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.